Groww Banking & Financial Services Fund - Direct Plan - Growth vs Nippon India Pharma Fund-Growth Plan-Bonus Option
Side-by-side comparison of NAV, returns, expense ratio and star rating.
TopFund Analysis
The Groww Banking & Financial Services Fund - Direct Plan - Growth appears stronger in terms of star rating with a 4-star rating compared to the 2-star rating of the Nippon India Pharma Fund-Growth Plan-Bonus Option, indicating better overall performance. However, while Groww's fund has a lower AUM of ₹106 Cr, Nippon India's fund boasts significantly higher AUM at ₹9166 Cr, which may suggest greater investor confidence. Additionally, the Nippon India fund offers higher returns over the 1-year and 3-year periods, but it comes with a slightly lower expense ratio at 0.99% compared to Groww's 1.3%. For investors deciding between these two funds, the choice may hinge on whether they prioritize higher returns or a better star rating.
Groww Banking & Financial Services Fund - Direct Plan - Growth
Groww Mutual Fund
★★★★★
Equity · Sectoral Fund
Nippon India Pharma Fund-Growth Plan-Bonus Option
Nippon India Mutual Fund
★★★★★
Equity · Sectoral Fund
| Metric | Groww Banking & Financ... | Nippon India Pharma Fu... |
|---|---|---|
| NAV | ₹13.59 | ₹582.42 |
| Star Rating | ★★★★ | ★★ |
| Expense Ratio | 1.3% | 0.99% |
| AUM | ₹106 Cr | ₹9,166 Cr |
| 1M Return | +5.06% | +8.53% |
| 3M Return | -0.15% | +2.09% |
| 6M Return | +9.01% | +6.88% |
| 1Y Return | +8.99% | +11.76% |
| 3Y CAGR | — | +16.54% |
| 5Y CAGR | — | +13.76% |
| Risk Level | — | — |
| Fund Manager | Anupam Tiwari | Sailesh Raj Bhan |